OpSens Inc. provided a business update in light of recent action taken by the province of Quebec regarding COVID-19. OpSens, which manufactures and distributes the OptoWire, a guidewire for physiological measurement used to determine the severity of blockages in patients with coronary artery stenosis as well as products utilized in ventricular assist devices, is exempt from the Quebec province order to close non-essential businesses until April 13, 2020. OpSens has, and will continue to, meet the needs of doctors and patients around the world who have come to rely upon the Company's essential diagnostic and treatment solutions. Thus far, the Company has had no manufacturing, supply chain, or distribution disruptions and has continued to fulfill orders to customers in each of its key geographies, including Japan, Europe, the United States and Canada. During these uncertain times, the Company is greatly appreciative of its talented and dedicated employees.  To safeguard their health and to ensure manufacturing continuity, the Company has implemented a series of proactive measures including the division of labor to multiple shifts and conversion of certain office employees to work remotely.